Shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the fourteen ratings firms that are presently covering the company, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to […]